soul trial oral semaglutide cardiovascular outcomes 2025 results New in the May 29, 2025, issue of NEJM: Sotatercept in Pulmonary Arterial Hypertension (ZENITH phase 3 trial) https://nej.md/4iYkLbj and (SOUL trial) https://nej.md/4hHII5M Upadacitinib for Giant-Cell Arteritis soul trial oral semaglutide cardiovascular

Ongoing Monitoring and Safety Your bloodwork tracks growth hormone levels, IGF-1 production, fasting glucose, insulin sensitivity, and liver function to catch any adverse effects early

The medication works by mimicking GLP-1's effects on appetite regulation and glucose metabolism

For example, you may be able to get coverage for liraglutide (generic Victoza) off-label for weight loss

The Ulta Lab Creatine Kinase test is an inexpensive test used by functional medical practitioners

Both peptides also act centrally stimulating hypothalamic GHRH neurons and antagonizing somatostatin tone, amplifying GH release beyond what pituitary-level action alone would produce

Lower doses might provide anti-inflammatory benefit with better tolerability